Want to join the conversation?
Drug maker $REGN said Sarilumab, the company's IL-6 receptor antibody for treatment of rheumatoid arthritis is under review with the FDA. Dupilumab is being developed for a number of indications and $REGN is targeting completion of its BLA submission for moderate-to-severe atopic dermatitis in 3Q16.
Looks like $BAC is regaining its lost reputation after the 2008 financial crisis. I hope the stock will flourish under Trump.
$BA won a $22 billion deal from SpiceJet, their largest order from an Indian airline.
$FB stock remained in the green territory after Raymond James upgraded shares to strong buy from outperform, on expectations that overall 4Q16 ad spending was strong.
$ARRY Good day for the stock, jumped 7%. Great gains !
2017 was supposed to be another record year for automotive industry. Still, $F Ford thinks its profit will dip in 2017..!!